RxDoctor Payments Data

Jorge Negron, MD

Gynecology · San Juan, PRNPI 1003855123

Payments from drug & device makers

What this record shows

10 manufacturers reported payments, led by Organon at 53.6% of the total. Reporting peaked in 2023 at $1,500 and has fallen 90.1% since, to $149 in 2025. Among gynecology clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,798in general payments, 2019–2025

Across 15 payments — averaging $186.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$2K
  • AbbVie$430
  • Roche Diagnostics Corporation$244
  • Boston Scientific$149
  • Davol Inc.$120
  • Gen-probe Sales & Service, Inc.$116
  • plus $239 from 4 others

What the payments were for

  • Consulting fees$1,50054%
  • Food & beverage$1,29846%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organon1$1,500
AbbVie4$430
Roche Diagnostics Corporation2$244
Boston Scientific2$149
Davol Inc.1$120
Gen-probe Sales & Service, Inc.1$116
Ferring Pharmaceuticals Inc.1$100
Abbott1$59
Gen-probe, Inc.1$55
Hologic Sales And Service, LLC1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,798 in reported general payments places this provider in the 90th percentile of 50 gynecology providers in Puerto Rico.

See all gynecology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$6,388
Medicare patients
43
Services billed
69

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol105$4,604
Tolterodine Tartrate ErTolterodine Tartrate15$1,723
Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet18$1,612
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip50$1,532
Raloxifene Hcl28$1,068
ProgesteroneProgesterone, Micronized24$908
Fluconazole70$573
Estradiol (Once Weekly)Estradiol11$567
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst27$402
Alendronate Sodium29$218

Paid to pharmacies, not to this prescriber.

Other gynecology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →